IP Library Granted Patent US 9,044,408
Granted Patent B2
US 9,044,408 · App. 13/285,458 · Granted Jun 2, 2015

Cosmetic use of N-heteroarylbisamide analogs and related compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,408
App. No.
13/285,458
Granted
Jun 2, 2015
Kind
B2
Abstract

Cosmetic and dermatological compositions comprising N-heteroarylbisamide analogs and methods of using such compositions to impart anti-aging benefits to the skin and/or improve skin conditions resulting from reduced collagen and hyaluronic acid production are disclosed. The N-heteroarylbisamides are believed to stimulate collagen and hyaluronic acid production and restore or maintain homeostasis for these compounds.

Claims (71)

1. A cosmetic composition for topical application to human skin comprising a cosmetically acceptable vehicle and a dermatologically effective amount of a N— heteroarylbisamide of Formula IA:

where:

R 2 , R 2′ , R 6 , and R 7 are independently H, C 1 -C 8 alkyl, heteroalkyl, alkoxyalkyl, heteroalkoxyalkyl, C 3 -C 8 cycloalkyl, heterocycloalkyl, aryl, heteroaryl, alkyl-aryl, heteroalkyl-aryl, aryl-alkyl, and/or heteroaryl-alkyl;

R 1 and R 5 are independently H, C 1 -C 8 alkyl, heteroalkyl, alkoxyalkyl, heteroalkoxyalkyl, C 3 -C 8 cycloalkyl, heterocycloalkyl, aryl, heteroaryl, alkyl-aryl, heteroalkyl-aryl, aryl-alkyl, and/or heteroaryl-alkyl or WR wherein W is CO, CO 2 , CONH, SO 2 , PO 3 , or CH(Oalkyl) 2 ; and

n is 1-4.

2. The cosmetic composition of claim 1 , wherein R 7 is H, halogen, or C 1 -C 4 alkyl or alkoxy.

3. The cosmetic composition of claim 2 , wherein R 7 is chlorine or methyl.

4. The cosmetic composition of claim 1 , wherein R 2 is C 1 -C 6 alkyl, or a C 6 aromatic hydrocarbon radical.

5. The cosmetic composition of claim 4 , wherein R 2 is methyl or tert-butyl.

6. The cosmetic composition of claim 1 , wherein R 2′ is H or phenyl.

7. The cosmetic composition of claim 1 , wherein R 6 is propyl, substituted propyl, or substituted phenyl.

8. The composition of claim 1 , wherein R 1 and R 5 are independently H, or lower alkyl.

9. The composition of claim 1 , wherein n is 3.

10. The cosmetic composition of claim 1 , wherein said N-heteroarylbisamide has the structure:

11. A method for improving the aesthetic appearance of human skin comprising topically applying to an area of the skin in need thereof an amount of the cosmetic composition of claim 1 to enhance the skin.

12. The method according to claim 11 , wherein the skin enhancement is an increase in the production of procollagen or collagen, and the aesthetic improvement is selected from the group consisting of:

(a) treatment and/or reduction of the appearance of fine lines or wrinkles,

(b) improvement of the skin's thickness, plumpness, and/or tautness;

(c) improvement in skin barrier repair and/or function;

(d) improvement in appearance of skin contours;

(e) increase in skin elasticity and/or resiliency;

(f) treatment and/or reduction of skin sagging;

(g) smooth scars and stretch marks; and/or

(h) reduction in pore size.

13. The method according to claim 11 , wherein the skin enhancement is an increase in the production of hyaluronic acid and the aesthetic improvement is selected from the group consisting of:

(a) improvement in the skin's suppleness, softness, tone, radiance, and/or clarity;

(b) improvement in skin texture and/or promotion of retexturization;

(c) restoration of skin luster and/or brightness;

(d) replenishment of essential nutrients and/or constituents in the skin; and/or

(e) improvement of skin moisturization and/or complexion.

14. The method according to claim 11 , wherein the skin enhancement is the modulation of fibroblasts and the aesthetic improvement is selected from the group consisting of:

(a) increase in the production of structural proteins and glucosaminoglycans;

(b) improvement in the structure of collagen;

(c) homoeostasis of structural protein and glucosaminoglycans;

(d) down-regulation of cytokine production;

(e) increased activation of fibroblasts to fibrocytes;

(f) increase in the viability and/or function of fibroblasts;

(g) improvement in maintenance and remodeling of elastin; and/or

(h) improvement in skin barrier repair and/or function.

15. The method according to claim 11 , wherein the skin enhancement is the modulation of kertinocytes and the aesthetic improvement is selected from the group consisting of:

(a) improve the viability and/or function of the keratinocytes

(b) down-regulate the production of inflammatory factors and/or cytokines;

(c) improve skin barrier repair and/or function;

(d) improve thickness of the epidermis;

(e) improve uniformity of epidermal cells;

(f) improvement in pigmentation; and/or

(g) smooth scars and stretch marks.

16. The method of claim 11 , wherein the skin enhancement is improving and maintaining the quality and viability of the extracellular matrix and the aesthetic improvements is selected from the group consisting of:

(a) treatment and/or reduction of the appearance of fine lines or wrinkles;

(b) improvement in the skin's thickness, plumpness, and/or tautness;

(c) improvement in skin barrier repair and/or function;

(d) improvement in appearance of skin contours;

(e) increased skin elasticity and/or resiliency;

(f) treatment and/or reduction of skin sagging;

(g) smoothing scars and stretch marks;

(h) reduction of pore size;

(i) improvement in the skin's suppleness, softness, tone, radiance, and/or clarity;

(j) improvement in the skin texture and/or promotion of its retexturization;

(k) restoration of skin luster and/or brightness;

(k) replenishment of essential nutrients and/or constituents in the skin; and/or

(l) improvement in skin moisturization and/or type.

17. The method according to claim 11 , wherein the skin enhancement is improving and maintaining the quality and viability of the epidermis and the aesthetic improvement is selected from the group consisting of:

(a) improvement in skin barrier repair and/or function;

(b) improvement of thickness of the epidermis;

(c) improvement in uniformity of epidermal cells;

(d) improvement in pigmentation; and/or

(e) smoothing scars and stretch marks.

18. The method of claim 11 wherein the dermatologically effective amount of the cosmetic composition is applied to the area of skin in need thereof for a time sufficient to improve the area of skin's aesthetic appearance.

19. The method according to claim 18 , wherein the composition is applied to said skin at least once daily for a period of at least four weeks.

20. The cosmetic composition of claim 1 , further comprising from about 0.0001% to about 25% by weight of the N-heteroarylbisamide of Formula I.

21. The cosmetic composition according to claim 1 , wherein said cosmetically acceptable vehicle comprises a water-in-oil or oil-in-water emulsion.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jan 28, 2026
From: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
To: AVON PRODUCTS, INC.
Reel/Frame 074508/0281 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2024
From: NATURA &CO HOLDING S.A.; NATURA COSMETICOS S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.A R.L. - LUXEMBOURG; NATURA &CO UK HOLDINGS LIMITED - UK
To: AVON PRODUCTS, INC
Reel/Frame 069591/0494 →
PATENT SECURITY AGREEMENT Recorded Aug 16, 2024
From: AVON PRODUCTS, INC.
To: NATURA &CO HOLDING S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L.; NATURA COSMÉTICOS S.A.; NATURA &CO UK HOLDINGS LIMITED
Reel/Frame 068659/0915 →
SECURITY INTEREST Recorded Apr 29, 2024
From: AVON PRODUCTS, INC.; MI HOLDINGS, INC.; AVON INTERNATIONAL OPERATIONS, INC.; AVON CAPITAL CORPORATION; AVON COSMETICS LIMITED; AVON BEAUTY LIMITED
To: NATURA &CO HOLDING S.A., AS SECURED PARTY; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA COSMÉTICOS S.A., AS A SECURED PARTY
Reel/Frame 067249/0491 →
SECURITY INTEREST Recorded Aug 11, 2023
From: AVON PRODUCTS, INC.
To: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
Reel/Frame 064566/0872 →
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 15, 2016
From: CITIBANK, N.A.
To: AVON PRODUCTS, INC.
Reel/Frame 039690/0331 →
SECURITY INTEREST Recorded Jun 12, 2015
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A.
Reel/Frame 035899/0776 →